Evaluation of the automated phoenix system for potential routine use in the clinical microbiology laboratory.

PubWeight™: 2.43‹?› | Rank: Top 2%

🔗 View Article (PMC 387561)

Published in J Clin Microbiol on April 01, 2004

Authors

J-L Donay1, D Mathieu, P Fernandes, C Prégermain, P Bruel, A Wargnier, I Casin, F X Weill, P H Lagrange, J L Herrmann

Author Affiliations

1: Service de Microbiologie, Hôpital Saint Louis, Paris, France.

Articles citing this

Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev (2008) 17.77

Comparison of Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometer to BD Phoenix automated microbiology system for identification of gram-negative bacilli. J Clin Microbiol (2011) 2.42

Use of the MicroSeq 500 16S rRNA gene-based sequencing for identification of bacterial isolates that commercial automated systems failed to identify correctly. J Clin Microbiol (2005) 1.94

Analysis of the comparative workflow and performance characteristics of the VITEK 2 and Phoenix systems. J Clin Microbiol (2005) 1.79

Phoenix 100 versus Vitek 2 in the identification of gram-positive and gram-negative bacteria: a comprehensive meta-analysis. J Clin Microbiol (2011) 1.65

Multicenter evaluation of the Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of Gram-positive aerobic bacteria. J Clin Microbiol (2013) 1.56

Evaluation of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of staphylococci and enterococci. J Clin Microbiol (2006) 1.31

Accuracies of beta-lactam susceptibility test results for Pseudomonas aeruginosa with four automated systems (BD Phoenix, MicroScan WalkAway, Vitek, and Vitek 2). J Clin Microbiol (2007) 1.25

High diversity of extended-spectrum beta-lactamase-producing bacteria in an urban river sediment habitat. Appl Environ Microbiol (2010) 1.23

Isolation of Pseudomonas aeruginosa from open ocean and comparison with freshwater, clinical, and animal isolates. Microb Ecol (2007) 1.23

Manual and automated instrumentation for identification of Enterobacteriaceae and other aerobic gram-negative bacilli. Clin Microbiol Rev (2005) 1.20

Evaluation of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of Enterobacteriaceae. J Clin Microbiol (2006) 1.16

Evaluation of the Phoenix 100 ID/AST system and NID panel for identification of Enterobacteriaceae, Vibrionaceae, and commonly isolated nonenteric gram-negative bacilli. J Clin Microbiol (2006) 1.14

Two-center collaborative evaluation of performance of the BD phoenix automated microbiology system for identification and antimicrobial susceptibility testing of gram-negative bacteria. J Clin Microbiol (2006) 1.07

Multi-center evaluation of the VITEK® MS system for mass spectrometric identification of non-Enterobacteriaceae Gram-negative bacilli. Eur J Clin Microbiol Infect Dis (2013) 1.07

Identification of clinical isolates of α-hemolytic streptococci by 16S rRNA gene sequencing, matrix-assisted laser desorption ionization-time of flight mass spectrometry using MALDI Biotyper, and conventional phenotypic methods: a comparison. J Clin Microbiol (2012) 1.05

Detecting imipenem resistance in Acinetobacter baumannii by automated systems (BD Phoenix, Microscan WalkAway, Vitek 2); high error rates with Microscan WalkAway. BMC Infect Dis (2009) 1.04

Use of the Phoenix automated system for identification of Streptococcus and Enterococcus spp. J Clin Microbiol (2006) 1.02

Comparative evaluation of Bruker Biotyper and BD Phoenix systems for identification of bacterial pathogens associated with urinary tract infections. J Clin Microbiol (2011) 0.95

Antibiotic susceptibility testing of grown blood cultures by combining culture and real-time polymerase chain reaction is rapid and effective. PLoS One (2011) 0.91

Automated Scoring of Chromogenic Media for Detection of Methicillin-Resistant Staphylococcus aureus by Use of WASPLab Image Analysis Software. J Clin Microbiol (2015) 0.87

Performance of Vitek 2 in antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates with different mechanisms of beta-lactam resistance. J Clin Microbiol (2008) 0.82

Comparison of an automated system with conventional identification and antimicrobial susceptibility testing. ISRN Microbiol (2012) 0.82

Novel concept microarray enabling PCR and multistep reactions through pipette-free aperture-to-aperture parallel transfer. BMC Biotechnol (2010) 0.79

Identification and antimicrobial susceptibility testing of Staphylococcus vitulinus by the BD phoenix automated microbiology system. Curr Microbiol (2008) 0.78

Narrow-spectrum cephalosporin susceptibility testing of Escherichia coli with the BD Phoenix automated system: questionable utility of cephalothin as a predictor of cephalexin susceptibility. J Clin Microbiol (2007) 0.77

Drug susceptibility testing of clinical isolates of streptococci and enterococci by the Phoenix automated microbiology system. BMC Microbiol (2007) 0.77

Evaluation of the inoculation procedure using a 0.25 McFarland standard for the BD Phoenix automated microbiology system. J Clin Microbiol (2007) 0.75

Comparison of the BD Phoenix system with the cefoxitin disk diffusion test for detection of methicillin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol (2009) 0.75

Species distribution and antibiotic susceptibility profile of bacterial uropathogens among patients complaining urinary tract infections. BMC Infect Dis (2017) 0.75

Articles cited by this

Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J Clin Microbiol (1994) 6.94

Clinical laboratory evaluation of the Abbott MS-2 automated antimicrobial susceptibility testing system: report of a collaborative study. J Clin Microbiol (1980) 5.99

Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci. Clin Microbiol Rev (1988) 5.13

Automated systems for identification of microorganisms. Clin Microbiol Rev (1992) 4.26

Evaluation of the VITEK 2 system for rapid identification of medically relevant gram-negative rods. J Clin Microbiol (1998) 4.07

Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother (1992) 3.56

Multiple antibiotic resistance and efflux. Curr Opin Microbiol (1998) 3.23

Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria. Antimicrob Agents Chemother (2000) 3.22

Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-screen latex agglutination test. J Clin Microbiol (2002) 3.05

Evaluation of an automated system for identification of Enterobacteriaceae and nonfermenting bacilli. Eur J Clin Microbiol Infect Dis (1999) 2.97

Outbreak of Klebsiella pneumoniae producing transferable AmpC-type beta-lactamase (ACC-1) originating from Hafnia alvei. FEMS Microbiol Lett (2000) 2.57

Evaluation of VITEK 2 rapid identification and susceptibility testing system against gram-negative clinical isolates. J Clin Microbiol (2001) 2.57

Comparison of the autoSCAN-W/A rapid bacterial identification system and the Vitek AutoMicrobic system for identification of gram-negative bacilli. J Clin Microbiol (1991) 2.51

Comparative evaluation of the BD Phoenix and VITEK 2 automated instruments for identification of isolates of the Burkholderia cepacia complex. J Clin Microbiol (2002) 2.16

Evaluation of autoSCAN-W/A automated microbiology system for the identification of non-glucose-fermenting gram-negative bacilli. J Clin Microbiol (1990) 2.13

Evaluation of the VITEK 2 system for identification and antimicrobial susceptibility testing of medically relevant gram-positive cocci. J Clin Microbiol (2002) 2.09

Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples. J Clin Microbiol (2001) 2.06

Clinical laboratory evaluation of the Auto-Microbic system for rapid identification of Enterobacteriaceae. J Clin Microbiol (1981) 2.02

Evaluation of a new system, VITEK 2, for identification and antimicrobial susceptibility testing of enterococci. J Clin Microbiol (2000) 1.78

Potential impact of the VITEK 2 system and the Advanced Expert System on the clinical laboratory of a university-based hospital. J Clin Microbiol (2001) 1.78

Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp. J Clin Microbiol (2002) 1.68

Two-center collaborative evaluation of the performance of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of Enterococcus spp. and Staphylococcus spp. J Clin Microbiol (2003) 1.56

Laboratory evaluation of the AutoMicrobic system for identification of Enterobacteriaceae. J Clin Microbiol (1981) 1.53

Evaluation of the AutoSCAN-3 and Sceptor systems for Enterobacteriaceae identification. J Clin Microbiol (1983) 1.47

Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix extended-spectrum beta-lactamase detection method. J Clin Microbiol (2003) 1.46

Identification and antimicrobial susceptibility testing of clinical isolates of nonfermenting gram-negative bacteria by the Phoenix Automated Microbiology System. New Microbiol (2002) 1.43

Comparison of the Vitek Gram-Positive Susceptibility 106 card and the MRSA-screen latex agglutination test for determining oxacillin resistance in clinical bloodstream isolates of Staphylococcus aureus. J Clin Microbiol (2001) 1.40

Comparison of MicroScan WalkAway system and Vitek system for identification of gram-negative bacteria. J Clin Microbiol (1995) 1.31

Evaluation of the Vitek 2 ID-GNB assay for identification of members of the family Enterobacteriaceae and other nonenteric gram-negative bacilli and comparison with the Vitek GNI+ card. J Clin Microbiol (2003) 1.26

Comparison of two automated instrument systems for rapid susceptibility testing of gram-negative bacilli. J Clin Microbiol (1983) 1.25

Induction/inhibition of chromosomal beta-lactamases by beta-lactamase inhibitors. Rev Infect Dis (1987) 1.23

The MicroScan WalkAway diagnostic microbiology system--an evaluation. Pathology (1995) 1.19

Comparative evaluation of the VITEK 2 Advanced Expert System (AES) in five UK hospitals. J Antimicrob Chemother (2003) 1.16

Comparison of the Vitek gram-positive susceptibility 106 card, the MRSA-Screen latex agglutination test, and mecA analysis for detecting oxacillin resistance in a geographically diverse collection of clinical isolates of coagulase-negative staphylococci. J Clin Microbiol (2001) 1.14

Accuracy of the VITEK 2 system to detect glycopeptide resistance in enterococci. J Clin Microbiol (2001) 1.08

Lack of additive effect between mechanisms of resistance to carbapenems and other beta-lactam agents in Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis (1995) 0.97

In vitro activity of combinations of beta-lactam antibiotics with beta-lactamase inhibitors against cephalosporinase-producing bacteria. Eur J Clin Microbiol Infect Dis (1989) 0.92

Differences between clavulanic acid and sulbactam in induction and inhibition of cephalosporinases in enterobacteria. J Int Med Res (1990) 0.85

Multicenter evaluation of an automated system using selected bacteria that harbor challenging and clinically relevant mechanisms of resistance to antibiotics. Eur J Clin Microbiol Infect Dis (2001) 0.83

Evaluation of the new VITEK 2 system for determination of the susceptibility of clinical isolates of Streptococcus pneumoniae. Chemotherapy (2002) 0.79

[Survey of the antibiotic sensitivity of Pseudomonas aeruginosa in France and the distribution of beta-lactam resistance mechanisms: the GERPB 1999 study]. Pathol Biol (Paris) (2001) 0.79

Articles by these authors

Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide. J Exp Med (1974) 5.73

Influence of dose and route of antigen injection on the immunological induction of T cells. J Exp Med (1974) 4.99

A simplified acute physiology score for ICU patients. Crit Care Med (1984) 4.55

Immunopotentiation with BCG. II. Modulation of the response to sheep red blood cells. J Natl Cancer Inst (1973) 4.10

Immunopotentiation with BCG. I. Immune response to different strains and preparations. J Natl Cancer Inst (1973) 3.20

Salmonella enteritidis: AmpC plasmid-mediated inducible beta-lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob Agents Chemother (1998) 3.17

Feedback inhibition of specifically sensitized lymphocytes. J Exp Med (1974) 3.11

A novel integron in Salmonella enterica serovar Enteritidis, carrying the bla(DHA-1) gene and its regulator gene ampR, originated from Morganella morganii. Antimicrob Agents Chemother (2000) 2.85

rRNA gene restriction patterns of Haemophilus influenzae biogroup aegyptius strains associated with Brazilian purpuric fever. J Clin Microbiol (1988) 2.75

Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 beta-lactamase and which were isolated in 14 French hospitals. J Clin Microbiol (1994) 2.66

Molecular characterisation by PCR-restriction fragment length polymorphism of TEM beta-lactamases. FEMS Microbiol Lett (1995) 2.63

Outbreak of Klebsiella pneumoniae producing transferable AmpC-type beta-lactamase (ACC-1) originating from Hafnia alvei. FEMS Microbiol Lett (2000) 2.57

Chromosomal beta-lactamase genes of Klebsiella oxytoca are divided into two main groups, blaOXY-1 and blaOXY-2. Antimicrob Agents Chemother (1996) 2.48

Periodic emission from the gamma-ray binary 1FGL J1018.6-5856. Science (2012) 2.40

A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire. J Hepatol (1999) 2.38

The modifying effect of BCG on the immunological induction of T cells. J Exp Med (1974) 2.30

An evaluation of the polymerase chain reaction amplicor Chlamydia trachomatis in male urine and female urogenital specimens. Sex Transm Dis (1994) 2.26

Molecular fingerprinting of Mycobacterium tuberculosis and risk factors for tuberculosis transmission in Paris, France, and surrounding area. J Clin Microbiol (1998) 2.17

Cholera-like illness due to Aeromonas sobria. J Infect Dis (1982) 2.13

Characterisation of CMY-4, an AmpC-type plasmid-mediated beta-lactamase in a Tunisian clinical isolate of Proteus mirabilis. FEMS Microbiol Lett (1998) 2.09

Origin and impact of plasmid-mediated extended-spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis (1994) 1.94

Diagnostic efficiency of endotracheal aspirates with quantitative bacterial cultures in intubated patients with suspected pneumonia. Comparison with the protected specimen brush. Am Rev Respir Dis (1993) 1.94

Comparison of genetic maps for two Leptospira interrogans serovars provides evidence for two chromosomes and intraspecies heterogeneity. J Bacteriol (1993) 1.91

Rapid diagnosis of extrapulmonary tuberculosis by PCR: impact of sample preparation and DNA extraction. J Clin Microbiol (2003) 1.91

Identification of clinical coagulase-negative staphylococci, isolated in microbiology laboratories, by matrix-assisted laser desorption/ionization-time of flight mass spectrometry and two automated systems. Clin Microbiol Infect (2009) 1.88

Characterization of FOX-3, an AmpC-type plasmid-mediated beta-lactamase from an Italian isolate of Klebsiella oxytoca. Antimicrob Agents Chemother (1998) 1.85

Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology (1996) 1.84

False-positive HIV antigens related to emergence of a 25-30 kD protein detected in organ recipients. AIDS (1992) 1.82

Susceptibility to leprosy is linked to the human NRAMP1 gene. J Infect Dis (1998) 1.79

Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome. Eur Respir J (2002) 1.79

Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology (1995) 1.78

New latex reagent using monoclonal antibodies to capsular polysaccharide for reliable identification of both oxacillin-susceptible and oxacillin-resistant Staphylococcus aureus. J Clin Microbiol (1993) 1.77

A TEM-derived extended-spectrum beta-lactamase in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1996) 1.77

Detection of 16 gamma-ray pulsars through blind frequency searches using the Fermi LAT. Science (2009) 1.74

A stable form of delayed-type hypersensitivity. J Exp Med (1975) 1.68

Focal nodular hyperplasia of the liver in men: is presentation the same in men and women? Gut (2002) 1.65

Modulated high-energy gamma-ray emission from the microquasar Cygnus X-3. Science (2009) 1.55

An epidemic of tuberculosis with a high rate of tuberculin anergy among a population previously unexposed to tuberculosis, the Yanomami Indians of the Brazilian Amazon. Proc Natl Acad Sci U S A (1997) 1.55

The imprint of the extragalactic background light in the gamma-ray spectra of blazars. Science (2012) 1.53

Point mutation in the pribnow box, the molecular basis of beta-lactamase overproduction in Klebsiella oxytoca. Antimicrob Agents Chemother (1995) 1.53

Lipoprotein access to MHC class I presentation during infection of murine macrophages with live mycobacteria. J Immunol (2001) 1.52

beta-lactamase gene promoters of 71 clinical strains of Klebsiella oxytoca. Antimicrob Agents Chemother (1996) 1.47

New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis. J Clin Microbiol (1999) 1.46

Risk factors for Clostridium difficile-associated diarrhoea in HIV-infected patients. AIDS (1993) 1.45

Genotypic identification of two groups within the species Bacteroides fragilis by ribotyping and by analysis of PCR-generated fragment patterns and insertion sequence content. J Bacteriol (1995) 1.44

Leprosy and BCG in southern Vietnam. Lancet (1990) 1.44

Diagnostic tests for pneumonia in ventilated patients: prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard. Am J Respir Crit Care Med (1995) 1.42

Deficit of interleukin 2 production associated with impaired T-cell proliferative responses in Mycobacterium lepraemurium infection. Infect Immun (1983) 1.42

Inhaled nitric oxide modulates leukocyte kinetics in the mesenteric venules of endotoxemic rats. Crit Care Med (2000) 1.41

First evidence of bacterial biofilms in the anaerobe part of scalp hair follicles: a pilot comparative study in folliculitis decalvans. J Eur Acad Dermatol Venereol (2012) 1.40

Dobutamine improves gastrointestinal mucosal blood flow in a porcine model of endotoxic shock. Crit Care Med (1997) 1.40

The Fermi Gamma-Ray Space Telescope discovers the pulsar in the young galactic supernova remnant CTA 1. Science (2008) 1.39

A cocoon of freshly accelerated cosmic rays detected by Fermi in the Cygnus superbubble. Science (2011) 1.39

[Role of hyperbaric oxygenation in the treatment of acute anaerobic infections]. Chirurgie (1992) 1.38

The immunology of leprosy: speculations on the leprosy spectrum. Rev Infect Dis (1981) 1.38

Fermi observations of high-energy gamma-ray emission from GRB 080916C. Science (2009) 1.37

Effects of bacterial lipopolysaccharide on the induction and expression of cell-mediated immunity. I. Depression of the afferent arc. J Immunol (1975) 1.37

Limits of commercial molecular tests for diagnosis of pulmonary tuberculosis. Eur Respir J (1997) 1.35

Outbreak of haemolytic uraemic syndrome and bloody diarrhoea due to Escherichia coli O104:H4, south-west France, June 2011. Euro Surveill (2011) 1.31

Plasmid-mediated rifampin resistance encoded by an arr-2-like gene cassette in Klebsiella pneumoniae producing an ACC-1 class C beta-lactamase. Antimicrob Agents Chemother (2001) 1.31

Intestinal microsporidiosis in human immunodeficiency virus-infected patients with chronic unexplained diarrhea: prevalence and clinical and biologic features. J Infect Dis (1993) 1.30

Klebsiella oxytoca: resistance to aztreonam by overproduction of the chromosomally encoded beta-lactamase. FEMS Microbiol Lett (1994) 1.30

Novel class A beta-lactamase Sed-1 from Citrobacter sedlakii: genetic diversity of beta-lactamases within the Citrobacter genus. Antimicrob Agents Chemother (2001) 1.29

Novel OXA-10-derived extended-spectrum beta-lactamases selected in vivo or in vitro. Antimicrob Agents Chemother (1998) 1.28

Bacillaene, a novel inhibitor of procaryotic protein synthesis produced by Bacillus subtilis: production, taxonomy, isolation, physico-chemical characterization and biological activity. J Antibiot (Tokyo) (1995) 1.25

Granulomatous reaction to intradermal injection of lepromin (Mitsuda reaction) is linked to the human NRAMP1 gene in Vietnamese leprosy sibships. J Infect Dis (2000) 1.25

Male urethritis with and without discharge: a clinical and microbiological study. Sex Transm Dis (1995) 1.25

Local immune response to Mycobacterium lepraemurium in C3H and C57Bl/6 mice. Clin Exp Immunol (1979) 1.24

A population of gamma-ray millisecond pulsars seen with the Fermi Large Area Telescope. Science (2009) 1.24

Cord blood T lymphocytes lack constitutive perforin expression in contrast to adult peripheral blood T lymphocytes. Blood (1995) 1.24

MR imaging in acute infectious cellulitis. Radiology (1994) 1.23

Systemic candidiasis in mice. II.--Main role of polymorphonuclear leukocytes in resistance to infection. Ann Immunol (Paris) (1980) 1.23

Viability, heat stability and immunogenicity of four BCG vaccines prepared from four different BCG strains. Ann Immunol (Paris) (1983) 1.23

Dynamic CT features of hepatic abscesses. Radiology (1985) 1.23

Lactobacillus species identification, H2O2 production, and antibiotic resistance and correlation with human clinical status. J Clin Microbiol (1999) 1.22

Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Lancet (1991) 1.20

A limit on the variation of the speed of light arising from quantum gravity effects. Nature (2009) 1.20

Antibiotic resistance in salmonellae isolated from humans and animals in France: comparative data from 1994 and 1997. J Antimicrob Chemother (2000) 1.20

Specific real-time PCR for simultaneous detection and identification of Legionella pneumophila serogroup 1 in water and clinical samples. Appl Environ Microbiol (2010) 1.17

Spinal vacuum phenomenon: CT diagnosis and significance. J Comput Assist Tomogr (1982) 1.15

Computed tomography of thoracic aortic dissection: accuracy and pitfalls. J Comput Assist Tomogr (1986) 1.13

The stability and immunogenicity of a dispersed-grown freeze-dried Pasteur BCG vaccine. J Biol Stand (1988) 1.12

Effects of bacterial lipopolysaccharide on the induction and expression of cell-mediated immunity. II. Stimulation of the efferent arc. J Immunol (1975) 1.11

Salmonella infections associated with reptiles: the current situation in Europe. Euro Surveill (2008) 1.11

Scattering of the rRNA genes on the physical map of the circular chromosome of Leptospira interrogans serovar icterohaemorrhagiae. J Bacteriol (1992) 1.10

Portal thrombosis: dynamic CT features and course. Radiology (1985) 1.09

Skeletal muscle microvascular blood flow and oxygen transport in patients with severe sepsis. Am J Respir Crit Care Med (1996) 1.09

Role of receptors and the cytoskeleton in reverse transformation and steroidogenesis induced by interferon. Ann N Y Acad Sci (1980) 1.08

Site of action of serum factors that block delayed-type hypersensitivity in mice. J Exp Med (1978) 1.07

Gamma-ray flares from the Crab Nebula. Science (2011) 1.07

In-vitro susceptibility of thirty strains of Haemophilus ducreyi to several antibiotics including six cephalosporins. J Antimicrob Chemother (1983) 1.07

Use of multilocus variable-number tandem repeat analysis (MLVA) in eight European countries, 2012. Euro Surveill (2013) 1.07

Complex segregation analysis of leprosy in southern Vietnam. Genet Epidemiol (1995) 1.06

Primary dissecting aneurysms of the coronary arteries: case report and literature review. Cardiovasc Intervent Radiol (1984) 1.06

Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J Biol Chem (1995) 1.06

Acute swelling of the limbs: magnetic resonance pictorial review of fascial and muscle signal changes. Eur J Radiol (1999) 1.05

Unusual increase in reported cases of paratyphoid A fever among travellers returning from Cambodia, January to September 2013. Euro Surveill (2013) 1.04